SpyPhage: A Cell-Free TXTL Platform for Rapid Engineering of Targeted Phage Therapies.
Resource type
Journal article
Date published
October 4, 2022
Project(s)
Priority 5: Enhanced Partnerships
Priority 2: Trait Diversity and Function
Funder
| Funder name | Awards |
Engineering and Physical Sciences Research Council, United Kingdom | BB/M017982/1 |
Defence Science and Technology Laboratory, United Kingdom | ACC101854 |
Medical and Life Sciences Research Fund, United Kingdom | 70442 |
Biotechnology and Biological Sciences Research Council, United Kingdom | BB/N011872/1 |
Biotechnology National Laboratory, Hungary | |
Journal title
ACS Synthetic Biology
Article number
acssynbio.2c00244
Publisher
American Chemical Society (ACS)
Place of publication
Washington, D.C., US
ISSN
2161-5063
eISSN
2161-5063
Official URL
Rights statement
In Copyright
Additional information
IF = 5.11 (2021-2022)